Literature DB >> 16585869

Petrous bone cholesteatoma: management and outcomes.

Ahmed Omran1, Giuseppe De Denato, Enrico Piccirillo, Olga Leone, Mario Sanna.   

Abstract

OBJECTIVE: Cholesteatoma of the petrous bone is a rare pathology that grows slowly and is often asymptomatic. High clinical suspect is recommended for its diagnosis. With the advancement of imaging, clinical diagnosis is confirmed and follow up is assured. The present study is presented to state our experience in management of petrous bone cholesteatoma (PBC) and an overview of the outcome results.
METHODS: This study was a retrospective case review conducted at a private quaternary referral center. From January 1984 to October 2004, 93 of 2,739 patients with chronic otitis media with cholesteatoma were treated surgically for PBC with varying location types.
RESULTS: The mean age in this study was 46 years. Ninety-four percent of patients presented with hearing loss. Facial paralysis constituted 55% of the presented manifestations and grade VI palsy was the most common. A massive type of PBC was found to affect 45% of patients and it was mainly the acquired pathology. The surgical approaches varied according to the class type of PBC. Postoperative complications were minimal, and follow up was carried out after 1 year from the surgery date.
CONCLUSION: Petrous bone cholesteatoma presents difficulties in its diagnosis and treatment. Adequate history-taking, high clinical suspicious, with the advancement of imaging techniques made its diagnosis more feasible. Improvement of the lateral skull base approaches rendered possible safe, adequate, and complete removal of the pathology.

Entities:  

Mesh:

Year:  2006        PMID: 16585869     DOI: 10.1097/01.mlg.0000208367.03963.ca

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  9 in total

1.  Endoscope-Assisted Surgery for Petrous Bone Cholesteatoma with Hearing Preservation.

Authors:  Kadir Serkan Orhan; Mehmet Çelik; Beldan Polat; Levent Aydemir; Aydın Aydoseli; Altay Sencer; Yahya Güldiken
Journal:  J Int Adv Otol       Date:  2019-12       Impact factor: 1.017

2.  Management of petrous bone cholesteatoma: open versus obliterative techniques.

Authors:  Fernando López Alvarez; Justo R Gómez; Ma Jesús Bernardo; Carlos Suárez
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-08-03       Impact factor: 2.503

3.  Our experience in the management of petrous bone cholesteatoma.

Authors:  Karine Aubry; Lana Kovac; Elisabeth Sauvaget; Patrice Tran Ba Huy; Philippe Herman
Journal:  Skull Base       Date:  2010-05

4.  Endoscopic transsphenoidal approach to petrous apex cholesteatoma.

Authors:  Karine Aubry; Romain Kania; Elisabeth Sauvaget; Patrice Tran Ba Huy; Philippe Herman
Journal:  Skull Base       Date:  2010-07

5.  Petrous Bone Cholesteatoma: Radical Excision with an Endeavour for Hearing Preservation.

Authors:  Suresh C Sharma; Smriti Panda; Alok Thakar; K Devaraja
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-04-25

6.  Wholly endoscopic permeatal removal of a petrous apex cholesteatoma.

Authors:  Todd Kanzara; Jagdeep Singh Virk; Sanjiv Chawda; Anthony O Owa
Journal:  Case Rep Otolaryngol       Date:  2014-12-07

7.  Petrous bone cholesteatoma: our experience of 20 years and management of two giant cases affecting rhinopharynx.

Authors:  Ya Liu; Fangyuan Wang; Weidong Shen; Jun Liu; Hui Zhao; Weiju Han; Lei Chen; Hu Yuan; Pu Dai; Dongyi Han; Shiming Yang; Zhaohui Hou
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-07-13       Impact factor: 2.503

8.  Giant Petrous Bone Cholesteatoma: Combined Microscopic Surgery and an Adjuvant Endoscopic Approach.

Authors:  Giannicola Iannella; Ersilia Savastano; Benedetta Pasquariello; Massimo Re; Giuseppe Magliulo
Journal:  J Neurol Surg Rep       Date:  2016-03

9.  Exteriorization of Petrous Bone Cholesteatoma by Endonasal Endoscopic Approach: A Case Report.

Authors:  Naoya Nishida; Takuya Fujiwara; Suehiro Satoshi; Akira Inoue; Daiki Takagi; Taro Takagi; Naohito Hato
Journal:  J Int Adv Otol       Date:  2021-07       Impact factor: 1.017

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.